DalsnaFinanceIPOs › Stoke Therapeutics, Inc.

Stoke Therapeutics, Inc. IPO

Completed

Stoke Therapeutics, Inc. completed its initial public offering on NASDAQ on June 19, 2019, pricing at $18.00 a share.

TickerSTOK
ExchangeNASDAQ
StatusCompleted
Listing dateJune 19, 2019
Offering price$18.00
Shares offered7,891,110
Total raised$142M

Company coverage

Stoke Therapeutics, Inc. — quote, profile and latest news →

Other recent IPOs

IPO data is compiled from SEC filings. This page is general information, not investment advice.